首页 > 最新文献

Multidisciplinary Respiratory Medicine最新文献

英文 中文
Cultural and linguistic validation of the NHQ-2 Questionnaire: a specific instrument for assessing patient's usability of inhalation devices. NHQ-2问卷的文化和语言验证:评估患者吸入装置可用性的特定工具。
IF 2.3 Pub Date : 2016-08-23 eCollection Date: 2016-01-01 DOI: 10.1186/s40248-016-0067-y
Roberto W Dal Negro, Massimiliano Povero

Background: An increasing number of inhalation devices are presently available in the market. They are differently characterized in terms of their handling and usability, both factors which may affect the outcomes of respiratory treatment. The assessment of the preference and the usability rate of all devices can be carried out by means of specific questionnaires. Before their use, the identification of errors due to the incorrect wording of questions included in the questionnaires, together with the trans-cultural reliability represents the main issues of their cultural and linguistic validation.

Methods and results: The New Handling Questionnaire - NHQ-2 is a novel specific questionnaire aimed to measure both the preference and the usability of all kinds of inhalation devices. The method used for its validation has been summarized in the first section of the present paper, while the results of the specific validation and translation process have been described in the second section, together with the grading of improvement achieved over the process. The comprehensibility and the reproducibility rates achieved for both the Italian and the English final versions of the NHQ-2 questionnaire were very high, such as >90 % for each question included.

Conclusions: The novel NHQ-2 questionnaire proved very high comprehensibility and reproducibility in both its Italian and English final versions. It can be proposed for the trans-cultural clinical use when the usability, and not only the patients' preference of devices, should be assessed.

背景:目前市场上有越来越多的吸入装置可供选择。它们在处理和可用性方面具有不同的特征,这两个因素都可能影响呼吸治疗的结果。对所有设备的偏好和可用性的评估可以通过具体的问卷进行。在使用问卷之前,对问卷中包含的问题措辞错误所导致的错误的识别,以及跨文化的信度是其文化和语言验证的主要问题。方法与结果:《新处理问卷- NHQ-2》是一份新型的专项问卷,旨在测量各类吸入装置的偏好和可用性。本文的第一部分总结了其验证方法,而第二部分描述了具体验证和翻译过程的结果,以及对该过程所取得的改进的分级。NHQ-2问卷的意大利语和英语定稿的可理解性和再现率都很高,每个问题的可理解性和再现率都> 90%。结论:新的NHQ-2问卷在意大利语和英语定稿中都具有很高的可理解性和可重复性。当评估设备的可用性,而不仅仅是患者对设备的偏好时,可以提出跨文化临床使用。
{"title":"Cultural and linguistic validation of the NHQ-2 Questionnaire: a specific instrument for assessing patient's usability of inhalation devices.","authors":"Roberto W Dal Negro,&nbsp;Massimiliano Povero","doi":"10.1186/s40248-016-0067-y","DOIUrl":"https://doi.org/10.1186/s40248-016-0067-y","url":null,"abstract":"<p><strong>Background: </strong>An increasing number of inhalation devices are presently available in the market. They are differently characterized in terms of their handling and usability, both factors which may affect the outcomes of respiratory treatment. The assessment of the preference and the usability rate of all devices can be carried out by means of specific questionnaires. Before their use, the identification of errors due to the incorrect wording of questions included in the questionnaires, together with the trans-cultural reliability represents the main issues of their cultural and linguistic validation.</p><p><strong>Methods and results: </strong>The New Handling Questionnaire - NHQ-2 is a novel specific questionnaire aimed to measure both the preference and the usability of all kinds of inhalation devices. The method used for its validation has been summarized in the first section of the present paper, while the results of the specific validation and translation process have been described in the second section, together with the grading of improvement achieved over the process. The comprehensibility and the reproducibility rates achieved for both the Italian and the English final versions of the NHQ-2 questionnaire were very high, such as >90 % for each question included.</p><p><strong>Conclusions: </strong>The novel NHQ-2 questionnaire proved very high comprehensibility and reproducibility in both its Italian and English final versions. It can be proposed for the trans-cultural clinical use when the usability, and not only the patients' preference of devices, should be assessed.</p>","PeriodicalId":49031,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"11 1","pages":"32"},"PeriodicalIF":2.3,"publicationDate":"2016-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s40248-016-0067-y","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34332805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Perimenstrual asthma: from pathophysiology to treatment strategies. 围经期哮喘:从病理生理学到治疗策略。
IF 2.3 Pub Date : 2016-08-01 eCollection Date: 2016-01-01 DOI: 10.1186/s40248-016-0065-0
Alessandra Graziottin, Audrey Serafini

The prevalence of asthma is about 9,7 % in women and 5,5 % in men. Asthma can deteriorate during the perimenstrual period, a phenomenon known as perimenstrual asthma (PMA), which represents a unique, highly symptomatic asthma phenotype. It is distinguished from traditional allergic asthma by aspirin sensitivity, less atopy, and lower lung capacity. PMA incidence is reported to vary between 19 and 40 % of asthmatic women. The presence of PMA has been related to increases in asthma-related emergency department visits, hospitalizations and emergency treatment including intubations. It is hypothesized that hormonal status may influence asthma in women, focusing on the role of sex hormones, and specifically on the impact of estrogens' fluctuations at ovulation and before periods. This paper will focus on the pathophysiology of hormone triggered cycle related inflammatory/allergic events and their relation with asthma. We reviewed the scientific literature on Pubmed database for studies on PMA. Key word were PMA, mastcells, estrogens, inflammation, oral contraception, hormonal replacement therapy (HRT), and hormone free interval (HFI). Special attention will be devoted to the possibility of reducing the perimenstrual worsening of asthma and associated symptoms by reducing estrogens fluctuations, with appropriate hormonal contraception and reduced HFI. This novel therapeutical approach will be finally discussed.

哮喘的发病率女性约为 9.7%,男性约为 5.5%。哮喘会在围经期恶化,这种现象被称为围经期哮喘(PMA),是一种独特的、症状严重的哮喘表型。它与传统的过敏性哮喘的区别在于对阿司匹林敏感、无特异性和肺活量较低。据报道,在哮喘女性中,PMA 的发病率在 19% 到 40% 之间。PMA 的出现与哮喘相关的急诊就诊、住院和急诊治疗(包括插管)的增加有关。据推测,荷尔蒙状态可能会影响女性哮喘,重点是性激素的作用,特别是排卵期和月经前雌激素波动的影响。本文将重点探讨激素引发的周期性炎症/过敏事件的病理生理学及其与哮喘的关系。我们在 Pubmed 数据库中查阅了有关 PMA 的科学文献。关键词包括 PMA、乳腺细胞、雌激素、炎症、口服避孕药、激素替代疗法(HRT)和无激素间期(HFI)。研究将特别关注通过减少雌激素波动、适当的激素避孕和缩短无激素间期来减轻哮喘围经期恶化和相关症状的可能性。最后将讨论这种新颖的治疗方法。
{"title":"Perimenstrual asthma: from pathophysiology to treatment strategies.","authors":"Alessandra Graziottin, Audrey Serafini","doi":"10.1186/s40248-016-0065-0","DOIUrl":"10.1186/s40248-016-0065-0","url":null,"abstract":"<p><p>The prevalence of asthma is about 9,7 % in women and 5,5 % in men. Asthma can deteriorate during the perimenstrual period, a phenomenon known as perimenstrual asthma (PMA), which represents a unique, highly symptomatic asthma phenotype. It is distinguished from traditional allergic asthma by aspirin sensitivity, less atopy, and lower lung capacity. PMA incidence is reported to vary between 19 and 40 % of asthmatic women. The presence of PMA has been related to increases in asthma-related emergency department visits, hospitalizations and emergency treatment including intubations. It is hypothesized that hormonal status may influence asthma in women, focusing on the role of sex hormones, and specifically on the impact of estrogens' fluctuations at ovulation and before periods. This paper will focus on the pathophysiology of hormone triggered cycle related inflammatory/allergic events and their relation with asthma. We reviewed the scientific literature on Pubmed database for studies on PMA. Key word were PMA, mastcells, estrogens, inflammation, oral contraception, hormonal replacement therapy (HRT), and hormone free interval (HFI). Special attention will be devoted to the possibility of reducing the perimenstrual worsening of asthma and associated symptoms by reducing estrogens fluctuations, with appropriate hormonal contraception and reduced HFI. This novel therapeutical approach will be finally discussed. </p>","PeriodicalId":49031,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"11 ","pages":"30"},"PeriodicalIF":2.3,"publicationDate":"2016-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967997/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34724652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obesity: systemic and pulmonary complications, biochemical abnormalities, and impairment of lung function. 肥胖:全身和肺部并发症、生化异常和肺功能损害。
IF 2.3 Pub Date : 2016-07-12 eCollection Date: 2016-01-01 DOI: 10.1186/s40248-016-0066-z
Thiago Thomaz Mafort, Rogério Rufino, Cláudia Henrique Costa, Agnaldo José Lopes

Obesity is currently one of the major epidemics of this millennium and affects individuals throughout the world. It causes multiple systemic complications, some of which result in severe impairment of organs and tissues. These complications involve mechanical changes caused by the accumulation of adipose tissue and the numerous cytokines produced by adipocytes. Obesity also significantly interferes with respiratory function by decreasing lung volume, particularly the expiratory reserve volume and functional residual capacity. Because of the ineffectiveness of the respiratory muscles, strength and resistance may be reduced. All these factors lead to inspiratory overload, which increases respiratory effort, oxygen consumption, and respiratory energy expenditure. It is noteworthy that patterns of body fat distribution significantly influence the function of the respiratory system, likely via the direct mechanical effect of fat accumulation in the chest and abdominal regions. Weight loss caused by various types of treatment, including low-calorie diet, intragastric balloon, and bariatric surgery, significantly improves lung function and metabolic syndrome and reduces body mass index. Despite advances in the knowledge of pulmonary and systemic complications associated with obesity, longitudinal randomized studies are needed to assess the impact of weight loss on metabolic syndrome and lung function.

肥胖目前是本世纪的主要流行病之一,影响着全世界的人。它会引起多种全身并发症,其中一些会导致器官和组织的严重损害。这些并发症包括由脂肪组织的积累和脂肪细胞产生的大量细胞因子引起的机械变化。肥胖还通过减少肺容量,特别是呼气储备容量和功能剩余容量,显著干扰呼吸功能。由于呼吸肌的无效,力量和阻力可能会降低。所有这些因素都会导致吸气超负荷,从而增加呼吸努力、耗氧量和呼吸能量消耗。值得注意的是,身体脂肪分布的模式显著影响呼吸系统的功能,可能是通过胸部和腹部脂肪积累的直接机械效应。通过低热量饮食、胃内球囊、减肥手术等多种治疗方法,可显著改善肺功能和代谢综合征,降低体重指数。尽管对与肥胖相关的肺部和全身并发症的了解有所进展,但仍需要纵向随机研究来评估减肥对代谢综合征和肺功能的影响。
{"title":"Obesity: systemic and pulmonary complications, biochemical abnormalities, and impairment of lung function.","authors":"Thiago Thomaz Mafort,&nbsp;Rogério Rufino,&nbsp;Cláudia Henrique Costa,&nbsp;Agnaldo José Lopes","doi":"10.1186/s40248-016-0066-z","DOIUrl":"https://doi.org/10.1186/s40248-016-0066-z","url":null,"abstract":"<p><p>Obesity is currently one of the major epidemics of this millennium and affects individuals throughout the world. It causes multiple systemic complications, some of which result in severe impairment of organs and tissues. These complications involve mechanical changes caused by the accumulation of adipose tissue and the numerous cytokines produced by adipocytes. Obesity also significantly interferes with respiratory function by decreasing lung volume, particularly the expiratory reserve volume and functional residual capacity. Because of the ineffectiveness of the respiratory muscles, strength and resistance may be reduced. All these factors lead to inspiratory overload, which increases respiratory effort, oxygen consumption, and respiratory energy expenditure. It is noteworthy that patterns of body fat distribution significantly influence the function of the respiratory system, likely via the direct mechanical effect of fat accumulation in the chest and abdominal regions. Weight loss caused by various types of treatment, including low-calorie diet, intragastric balloon, and bariatric surgery, significantly improves lung function and metabolic syndrome and reduces body mass index. Despite advances in the knowledge of pulmonary and systemic complications associated with obesity, longitudinal randomized studies are needed to assess the impact of weight loss on metabolic syndrome and lung function. </p>","PeriodicalId":49031,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"11 ","pages":"28"},"PeriodicalIF":2.3,"publicationDate":"2016-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s40248-016-0066-z","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34552232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 203
High bacterial load of indoor air in hospital wards: the case of University of Gondar teaching hospital, Northwest Ethiopia. 医院病房室内空气细菌负荷高:以埃塞俄比亚西北部贡达尔大学教学医院为例
IF 2.3 Pub Date : 2016-07-05 eCollection Date: 2016-01-01 DOI: 10.1186/s40248-016-0061-4
Zemichael Gizaw, Mulat Gebrehiwot, Chalachew Yenew

Background: The air inhaled by people is abundantly populated with microorganisms which also are called bioaerosols. Bioaerosols is a colloidal suspension, formed by liquid droplets and particles of solid matter in the air, whose components contain or have attached to them viruses, fungal spores and conidia, bacterial endospores, plant pollen and fragments of plant tissues. They account for 5-34 % of indoor air pollution.

Methods: A cross-sectional study was conducted to assess the bacteriological concentration and to identify specific species of bacteria in the indoor air of Gondar University teaching hospital. Air samples were taken from 14 randomly selected wards. Bacterial measurements were made by passive air sampling technique i.e., the settle plate method. In each ward five Petri dishes were exposed for 30 and 60 min in the morning and afternoon. Bacteria were collected on nutrient agar and blood agar media. Both quantitative and qualitative analyses were conducted. The quantitative analysis was mainly conducted to determine bacterial load or number of bacteria in the indoor air. Bacterial load was enumerated as colony forming units. Qualitative analysis was conducted to identify specific species of bacteria. For this study we have selected Staphylococcus aureus and Streptococcus which had high public health concern. Mannitol test was used to isolate Staphylococcus aureus, whereas Bacitracin test was conducted to isolate Streptococcus pyogene.

Result: The result of this study indicated that the highest bacterial load which was 1468 CFU/m(3) has been recorded at 2:00 PM in Ward C at 60 min exposure time and the lowest bacterial concentration (i.e., 480 CFU/m(3)) was recorded at 8:00 AM in physiotherapy ward. Based on the result bacterial concentration of indoor air of Gondar University teaching hospital was found between 480 and 1468 CFU/m(3). The result of one way ANOVA showed that the highest mean bacterial concentration (1271.00 CFU/m(3)) was found in Medical ward and the least (583.25 CFU/m(3)) concentration was found in ward D and the grand total average concentration was 878.43 CFU/m(3). Favorable conditions for growth and multiplication of bacteria like temperature (26.5-29.5 °C), humidity (64.5-85 %), presence of unhygienic attached toilets, poor waste management system and poor ventilation system were observed during the survey. Staphylococcus aureus was identified in 10 wards and Streptococcus pyogenes was isolated in 8 hospital wards.

Conclusions: Compared with different indoor air biological standards, higher concentration of indoor air bacterial load was found in Gondar University teaching hospital. The higher bacterial load may be due to temperature, humidity, presence of unhygienic attached toilets, poor waste management system and poor ventilation system. Therefore, attention must be given to control those environmental factors which fav

背景:人们吸入的空气中充满了微生物,这些微生物也被称为生物气溶胶。生物气溶胶是由空气中固体物质的液滴和颗粒形成的胶体悬浮液,其成分含有或附着在其上的病毒、真菌孢子和分生孢子、细菌内生孢子、植物花粉和植物组织碎片。它们占室内空气污染的5- 34%。方法:采用横断面法对刚达尔大学附属医院室内空气进行细菌浓度测定和细菌种类鉴定。随机抽取14个病房的空气样本。细菌测量采用被动空气采样技术,即沉降板法。每个病房5个培养皿分别于上午和下午暴露30和60分钟。在营养琼脂和血琼脂培养基上采集细菌。进行了定量和定性分析。定量分析主要是测定室内空气中的细菌负荷或细菌数量。细菌负荷被列为菌落形成单位。进行了定性分析,以确定特定的细菌种类。在本研究中,我们选择了具有高度公共卫生关注的金黄色葡萄球菌和链球菌。用甘露醇试验分离金黄色葡萄球菌,用杆菌肽试验分离化脓性链球菌。结果:本研究结果显示,暴露时间60min的C病区下午2:00细菌负荷最高,为1468 CFU/m(3);物理治疗病区上午8:00细菌浓度最低,为480 CFU/m(3)。结果冈达尔大学附属医院室内空气细菌浓度为480 ~ 1468 CFU/m(3)。单因素方差分析结果显示,内科病房平均细菌浓度最高(1271.00 CFU/m(3)), D病房最低(583.25 CFU/m(3)),总平均浓度为878.43 CFU/m(3)。在调查期间,观察到细菌生长和繁殖的有利条件,如温度(26.5-29.5°C)、湿度(64.5- 85%)、不卫生的附属厕所、不良的废物管理系统和不良的通风系统。10个病房检出金黄色葡萄球菌,8个病房检出化脓性链球菌。结论:与不同室内空气生物标准相比,冈达尔大学教学医院室内空气细菌负荷浓度较高。较高的细菌负荷可能是由于温度、湿度、不卫生的附属厕所、不良的废物管理系统和不良的通风系统。因此,必须注意控制室内环境中有利于微生物生长和繁殖的环境因素。此外,小区的通风条件、厕所清洁度、清扫方式和垃圾处理系统也应得到改善。
{"title":"High bacterial load of indoor air in hospital wards: the case of University of Gondar teaching hospital, Northwest Ethiopia.","authors":"Zemichael Gizaw,&nbsp;Mulat Gebrehiwot,&nbsp;Chalachew Yenew","doi":"10.1186/s40248-016-0061-4","DOIUrl":"https://doi.org/10.1186/s40248-016-0061-4","url":null,"abstract":"<p><strong>Background: </strong>The air inhaled by people is abundantly populated with microorganisms which also are called bioaerosols. Bioaerosols is a colloidal suspension, formed by liquid droplets and particles of solid matter in the air, whose components contain or have attached to them viruses, fungal spores and conidia, bacterial endospores, plant pollen and fragments of plant tissues. They account for 5-34 % of indoor air pollution.</p><p><strong>Methods: </strong>A cross-sectional study was conducted to assess the bacteriological concentration and to identify specific species of bacteria in the indoor air of Gondar University teaching hospital. Air samples were taken from 14 randomly selected wards. Bacterial measurements were made by passive air sampling technique i.e., the settle plate method. In each ward five Petri dishes were exposed for 30 and 60 min in the morning and afternoon. Bacteria were collected on nutrient agar and blood agar media. Both quantitative and qualitative analyses were conducted. The quantitative analysis was mainly conducted to determine bacterial load or number of bacteria in the indoor air. Bacterial load was enumerated as colony forming units. Qualitative analysis was conducted to identify specific species of bacteria. For this study we have selected Staphylococcus aureus and Streptococcus which had high public health concern. Mannitol test was used to isolate Staphylococcus aureus, whereas Bacitracin test was conducted to isolate Streptococcus pyogene.</p><p><strong>Result: </strong>The result of this study indicated that the highest bacterial load which was 1468 CFU/m(3) has been recorded at 2:00 PM in Ward C at 60 min exposure time and the lowest bacterial concentration (i.e., 480 CFU/m(3)) was recorded at 8:00 AM in physiotherapy ward. Based on the result bacterial concentration of indoor air of Gondar University teaching hospital was found between 480 and 1468 CFU/m(3). The result of one way ANOVA showed that the highest mean bacterial concentration (1271.00 CFU/m(3)) was found in Medical ward and the least (583.25 CFU/m(3)) concentration was found in ward D and the grand total average concentration was 878.43 CFU/m(3). Favorable conditions for growth and multiplication of bacteria like temperature (26.5-29.5 °C), humidity (64.5-85 %), presence of unhygienic attached toilets, poor waste management system and poor ventilation system were observed during the survey. Staphylococcus aureus was identified in 10 wards and Streptococcus pyogenes was isolated in 8 hospital wards.</p><p><strong>Conclusions: </strong>Compared with different indoor air biological standards, higher concentration of indoor air bacterial load was found in Gondar University teaching hospital. The higher bacterial load may be due to temperature, humidity, presence of unhygienic attached toilets, poor waste management system and poor ventilation system. Therefore, attention must be given to control those environmental factors which fav","PeriodicalId":49031,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"11 ","pages":"24"},"PeriodicalIF":2.3,"publicationDate":"2016-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s40248-016-0061-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34542656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 54
Most Italians attending a congress on health of elderly people do not know and do not recognize respiratory diseases. 参加老年人健康大会的大多数意大利人不知道也不承认呼吸系统疾病。
IF 2.3 Pub Date : 2016-07-05 eCollection Date: 2016-01-01 DOI: 10.1186/s40248-016-0062-3
Nicola Ciancio, Claudio M Sanguinetti, Franco Falcone, Claudio Taranto, Roberto Fasani, Fernando De Benedetto, Onofrio Resta, Fausto De Michele, Roberto Messina, Andrea Rossi, Stefano Nardini, Giuseppe Di Maria

Background: The present study reports the results of a survey jointly carried out by three Italian respiratory scientific associations (AIMAR, AIPO, SIMeR) together with an important Federation of elderly patients (FederAnziani) during the National Conference of Italian Court for Health Right held in Rimini from November 29(th) to December 1(st), 2013. The survey, based on a spirometric examination preceded by a questionnaire on respiratory health, was conducted on elderly people coming from all Italian regions to attend the Conference.

Methods: Nine hundred forty-nine subjects (574 females and 375 males), mean age 66.2 ± 10.1 years, were interviewed and performed spirometric examination. There were 137 smokers (14.4 %). Mean value of Body Mass Index (BMI) was significantly higher in males (27.6 ± 6.6) than in females (26.3 ± 4.3).

Results: 17.1 % (N = 143) of the studied subjects reported to be suffering from respiratory disease and the prevalent illnesses were asthma (31.5 %) and COPD/emphysema (24.5 %), but only 3.3 % of the whole surveyed group was able to identify COPD as a pulmonary disease, however without knowing its characteristics, while these were known by 0.5 % of the interviewed subjects only. A high number of subjects, 22 % of whom were smokers, declared chronic sputum production. 10.2 % of the study group showed an obstructive defect at spirometry when the criterium of lower limit of the normal (LLN) was considered, whereas it was 12.4 % if the fixed limit of 0.70 was chosen. 64 % of the obstructed people thought they did not have any respiratory disease.

Conclusions: The results of this survey, able to spread the knowledge of respiratory diseases and spirometry in a wide sample of subjects for the most part scarcely aware of them, emphasize the need for a greater divulgation of respiratory issues among the general population.

背景:本研究报告了2013年11月29日至12月1日在里米尼举行的意大利健康权利法院全国会议期间,意大利三个呼吸科学协会(AIMAR, AIPO, SIMeR)和一个重要的老年患者联合会(FederAnziani)共同进行的调查结果。这项调查是对来自意大利所有参加会议的地区的老年人进行的,在进行呼吸健康问卷调查之前进行了肺活量测定检查。方法:对949例受试者(女性574例,男性375例)进行访谈和肺活量测定,平均年龄66.2±10.1岁。吸烟者137人(14.4%)。男性体重指数(BMI)平均值(27.6±6.6)明显高于女性(26.3±4.3)。结果:17.1% (N = 143)的研究对象报告患有呼吸系统疾病,流行的疾病是哮喘(31.5%)和COPD/肺气肿(24.5%),但整个调查群体中只有3.3%的人能够确定COPD是一种肺部疾病,但不知道其特征,而这些只有0.5%的受访对象知道。大量受试者,其中22%是吸烟者,宣称慢性痰产生。以正常下限(LLN)为肺量测定标准时,10.2%的研究组出现阻塞性肺缺陷,而以0.70为固定界限时,12.4%的研究组出现阻塞性肺缺陷。64%的患者认为自己没有呼吸道疾病。结论:这项调查的结果,能够传播呼吸系统疾病和肺活量测定的知识,在大多数人几乎没有意识到他们的广泛样本,强调需要在一般人群中更多地透露呼吸系统问题。
{"title":"Most Italians attending a congress on health of elderly people do not know and do not recognize respiratory diseases.","authors":"Nicola Ciancio,&nbsp;Claudio M Sanguinetti,&nbsp;Franco Falcone,&nbsp;Claudio Taranto,&nbsp;Roberto Fasani,&nbsp;Fernando De Benedetto,&nbsp;Onofrio Resta,&nbsp;Fausto De Michele,&nbsp;Roberto Messina,&nbsp;Andrea Rossi,&nbsp;Stefano Nardini,&nbsp;Giuseppe Di Maria","doi":"10.1186/s40248-016-0062-3","DOIUrl":"https://doi.org/10.1186/s40248-016-0062-3","url":null,"abstract":"<p><strong>Background: </strong>The present study reports the results of a survey jointly carried out by three Italian respiratory scientific associations (AIMAR, AIPO, SIMeR) together with an important Federation of elderly patients (FederAnziani) during the National Conference of Italian Court for Health Right held in Rimini from November 29(th) to December 1(st), 2013. The survey, based on a spirometric examination preceded by a questionnaire on respiratory health, was conducted on elderly people coming from all Italian regions to attend the Conference.</p><p><strong>Methods: </strong>Nine hundred forty-nine subjects (574 females and 375 males), mean age 66.2 ± 10.1 years, were interviewed and performed spirometric examination. There were 137 smokers (14.4 %). Mean value of Body Mass Index (BMI) was significantly higher in males (27.6 ± 6.6) than in females (26.3 ± 4.3).</p><p><strong>Results: </strong>17.1 % (N = 143) of the studied subjects reported to be suffering from respiratory disease and the prevalent illnesses were asthma (31.5 %) and COPD/emphysema (24.5 %), but only 3.3 % of the whole surveyed group was able to identify COPD as a pulmonary disease, however without knowing its characteristics, while these were known by 0.5 % of the interviewed subjects only. A high number of subjects, 22 % of whom were smokers, declared chronic sputum production. 10.2 % of the study group showed an obstructive defect at spirometry when the criterium of lower limit of the normal (LLN) was considered, whereas it was 12.4 % if the fixed limit of 0.70 was chosen. 64 % of the obstructed people thought they did not have any respiratory disease.</p><p><strong>Conclusions: </strong>The results of this survey, able to spread the knowledge of respiratory diseases and spirometry in a wide sample of subjects for the most part scarcely aware of them, emphasize the need for a greater divulgation of respiratory issues among the general population.</p>","PeriodicalId":49031,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"11 ","pages":"26"},"PeriodicalIF":2.3,"publicationDate":"2016-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s40248-016-0062-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34542657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Sarcoidosis with prevalent and severe joint localization: a case report. 结节病伴普遍严重关节局部化1例。
IF 2.3 Pub Date : 2016-06-29 eCollection Date: 2016-01-01 DOI: 10.1186/s40248-016-0064-1
Livio G Moccia, Sabrina Castaldo, Emanuela Sirignano, Maddalena Napolitano, Enrica Barra, Alessandro Sanduzzi

Background: Sarcoidosis is a systemic granulomatous disease of unknown origin, characterized by the formation of granulomas without central necrosis. Each organ and tissue can be affected by the disease, but in most cases mainly the lungs and mediastinal lymph nodes but also skin, heart, eyes and joints are involved, the latter are mainly the metacarpophalangeal joints and bone lesions are often associated with involvement of the overlying skin. The diagnosis is often of exclusion, based on clinical and radiological suspicion, and should be confirmed by biopsy, although in each case it is necessary to exclude other possible causes of granulomatosis, including infections by mycobacteria. Here it is reported a case of particularly aggressive sarcoidosis with primitive involvement of the small joints of the hands and feet, and mediastinal lymph nodes.

Case presentation: The subject, a man, 60 years old, born in Morocco but living in Italy for many years, presented important involvement of bone structures and soft periarticular tissue, and was affected by the formation of granulomas without "caseum necrosis". The painful symptoms and the skin ulceration had led to surgical amputation of the distal phalanges of most fingers of his hands and feet, but with subsequent resurgence of lesions in acral locations after surgery. The PET/CT scan showed an amount of radiotracer in mediastinal lymph nodes, while the lymph nodes sampled by TBNA were normal and the CD4/CD8 ratio was less than 3 in the bronchoalveolar lavage. We ruled out any possible infectious cause, including mycobacterial infection (both tubercular and atypical), so the patient was treated with systemic corticosteroids, with an excellent clinical and radiological response.

Conclusions: Such a case shows how the disease can have variable expressions, without primitive lung involvement; therefore, it should be necessary to consider any possible, unpredictable localization of the disease.

背景:结节病是一种来源不明的全身性肉芽肿性疾病,其特征是肉芽肿的形成没有中心坏死。每个器官和组织都可受到疾病的影响,但在大多数情况下主要是肺和纵隔淋巴结,但也包括皮肤、心脏、眼睛和关节,后者主要是掌指关节和骨病变通常与上覆皮肤受累有关。诊断通常是排除性的,基于临床和放射学的怀疑,并应通过活检证实,尽管在每个病例中都有必要排除其他可能的肉芽肿病原因,包括分枝杆菌感染。本文报告一例侵袭性结节病,原发累及手脚小关节和纵隔淋巴结。病例介绍:患者为男性,60岁,摩洛哥出生,意大利居住多年,主要累及骨结构和关节周围软组织,并伴有肉芽肿形成,无“干酪样坏死”。疼痛症状和皮肤溃疡导致手术截肢其手和脚的大多数手指的远端指骨,但随后手术后在肢端部位复发病变。PET/CT扫描显示纵隔淋巴结可见一定量的示踪剂,而TBNA取样淋巴结正常,支气管肺泡灌洗液CD4/CD8比值小于3。我们排除了任何可能的感染原因,包括分枝杆菌感染(结核性和非典型),因此患者接受全身皮质类固醇治疗,临床和放射学反应良好。结论:该病例显示了该疾病如何具有可变表达,而没有原始肺部受累;因此,有必要考虑任何可能的、不可预测的疾病定位。
{"title":"Sarcoidosis with prevalent and severe joint localization: a case report.","authors":"Livio G Moccia,&nbsp;Sabrina Castaldo,&nbsp;Emanuela Sirignano,&nbsp;Maddalena Napolitano,&nbsp;Enrica Barra,&nbsp;Alessandro Sanduzzi","doi":"10.1186/s40248-016-0064-1","DOIUrl":"https://doi.org/10.1186/s40248-016-0064-1","url":null,"abstract":"<p><strong>Background: </strong>Sarcoidosis is a systemic granulomatous disease of unknown origin, characterized by the formation of granulomas without central necrosis. Each organ and tissue can be affected by the disease, but in most cases mainly the lungs and mediastinal lymph nodes but also skin, heart, eyes and joints are involved, the latter are mainly the metacarpophalangeal joints and bone lesions are often associated with involvement of the overlying skin. The diagnosis is often of exclusion, based on clinical and radiological suspicion, and should be confirmed by biopsy, although in each case it is necessary to exclude other possible causes of granulomatosis, including infections by mycobacteria. Here it is reported a case of particularly aggressive sarcoidosis with primitive involvement of the small joints of the hands and feet, and mediastinal lymph nodes.</p><p><strong>Case presentation: </strong>The subject, a man, 60 years old, born in Morocco but living in Italy for many years, presented important involvement of bone structures and soft periarticular tissue, and was affected by the formation of granulomas without \"caseum necrosis\". The painful symptoms and the skin ulceration had led to surgical amputation of the distal phalanges of most fingers of his hands and feet, but with subsequent resurgence of lesions in acral locations after surgery. The PET/CT scan showed an amount of radiotracer in mediastinal lymph nodes, while the lymph nodes sampled by TBNA were normal and the CD4/CD8 ratio was less than 3 in the bronchoalveolar lavage. We ruled out any possible infectious cause, including mycobacterial infection (both tubercular and atypical), so the patient was treated with systemic corticosteroids, with an excellent clinical and radiological response.</p><p><strong>Conclusions: </strong>Such a case shows how the disease can have variable expressions, without primitive lung involvement; therefore, it should be necessary to consider any possible, unpredictable localization of the disease.</p>","PeriodicalId":49031,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"11 ","pages":"27"},"PeriodicalIF":2.3,"publicationDate":"2016-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s40248-016-0064-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34687494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Evaluation of the rapid immunochromatographic ODK0501 assay for Streptococcus pneumoniae antigen detection with nasopharyngeal swabs: preliminary report. 快速免疫层析ODK0501法检测鼻咽拭子肺炎链球菌抗原的初步报告
IF 2.3 Pub Date : 2016-06-20 eCollection Date: 2016-01-01 DOI: 10.1186/s40248-016-0060-5
Shoji Suzuki, Naoki Nishimura, Torahiko Jinta, Yasuhiko Yamano, Genta Ishikawa, Yutaka Tomishima, Noboru Uchiyama, Naohiko Chohnabayashi

Background: Early identification and control of pathogenic bacteria are important in the treatment of pneumonia. Currently, two rapid antigen detection kits for pneumococcal pneumonia are available: one uses urine samples and the other, named RAPIRUN® S. pneumoniae, uses sputum samples. RAPIRUN® has shown high sensitivity with nasopharyngeal swab samples from pediatric patients. In this study, we investigated the performance of RAPIRUN® with nasopharyngeal swabs from adult patients.

Methods: All adult patients diagnosed with pneumonia from November 2011 to April 2012 in St. Luke's International hospital were included in this cross-sectional study. Single sputum, nasopharyngeal swab, and urine samples obtained from patients were investigated using a rapid antigen detection kit. Sputum and blood cultures were also evaluated. We compared the characteristics of pneumococcal pneumonia patients diagnosed using RAPIRUN with a nasopharyngeal swab to those patients diagnosed using other methods. Sensitivity and specificity were also calculated.

Results: Seventeen out of 60 patients with pneumonia were diagnosed with pneumococcal pneumonia. In 4 out  of the 17 cases, a positive test result was obtained using RAPIRUN with a nasopharyngeal swab. The sensitivity and specificity were 23.5 and 100 %, respectively.

Conclusion: RAPIRUN performed with nasopharyngeal swabs from adult patients exhibited lower sensitivity for the diagnosis of pneumococcal pneumonia than the other compared methods. The causative pathogen of pneumonia should be identified using not only sputum cultures or rapid antigen detection kits but also clinical features or gram staining of sputum.

背景:早期识别和控制病原菌对肺炎的治疗具有重要意义。目前,有两种用于肺炎球菌肺炎的快速抗原检测试剂盒:一种使用尿液样本,另一种使用痰样本,名为RAPIRUN®S. pneumoniae。RAPIRUN®对儿科患者鼻咽拭子样本显示出高敏感性。在这项研究中,我们研究了RAPIRUN®对成人患者鼻咽拭子的作用。方法:选取2011年11月至2012年4月在圣路加国际医院诊断为肺炎的所有成年患者进行横断面研究。使用快速抗原检测试剂盒对患者的单口痰、鼻咽拭子和尿液样本进行调查。痰和血培养也进行了评估。我们比较了使用RAPIRUN和鼻咽拭子诊断的肺炎球菌肺炎患者与使用其他方法诊断的患者的特征。同时计算敏感性和特异性。结果:60例肺炎患者中有17例诊断为肺炎球菌性肺炎。在17例病例中,4例使用RAPIRUN和鼻咽拭子获得阳性检测结果。敏感性和特异性分别为23.5%和100%。结论:成人患者鼻咽拭子联合RAPIRUN诊断肺炎球菌性肺炎的敏感性低于其他比较方法。肺炎的病原鉴定不仅应使用痰培养或快速抗原检测试剂盒,还应使用临床特征或痰革兰氏染色。
{"title":"Evaluation of the rapid immunochromatographic ODK0501 assay for Streptococcus pneumoniae antigen detection with nasopharyngeal swabs: preliminary report.","authors":"Shoji Suzuki,&nbsp;Naoki Nishimura,&nbsp;Torahiko Jinta,&nbsp;Yasuhiko Yamano,&nbsp;Genta Ishikawa,&nbsp;Yutaka Tomishima,&nbsp;Noboru Uchiyama,&nbsp;Naohiko Chohnabayashi","doi":"10.1186/s40248-016-0060-5","DOIUrl":"https://doi.org/10.1186/s40248-016-0060-5","url":null,"abstract":"<p><strong>Background: </strong>Early identification and control of pathogenic bacteria are important in the treatment of pneumonia. Currently, two rapid antigen detection kits for pneumococcal pneumonia are available: one uses urine samples and the other, named RAPIRUN® S. pneumoniae, uses sputum samples. RAPIRUN® has shown high sensitivity with nasopharyngeal swab samples from pediatric patients. In this study, we investigated the performance of RAPIRUN® with nasopharyngeal swabs from adult patients.</p><p><strong>Methods: </strong>All adult patients diagnosed with pneumonia from November 2011 to April 2012 in St. Luke's International hospital were included in this cross-sectional study. Single sputum, nasopharyngeal swab, and urine samples obtained from patients were investigated using a rapid antigen detection kit. Sputum and blood cultures were also evaluated. We compared the characteristics of pneumococcal pneumonia patients diagnosed using RAPIRUN with a nasopharyngeal swab to those patients diagnosed using other methods. Sensitivity and specificity were also calculated.</p><p><strong>Results: </strong>Seventeen out of 60 patients with pneumonia were diagnosed with pneumococcal pneumonia. In 4 out  of the 17 cases, a positive test result was obtained using RAPIRUN with a nasopharyngeal swab. The sensitivity and specificity were 23.5 and 100 %, respectively.</p><p><strong>Conclusion: </strong>RAPIRUN performed with nasopharyngeal swabs from adult patients exhibited lower sensitivity for the diagnosis of pneumococcal pneumonia than the other compared methods. The causative pathogen of pneumonia should be identified using not only sputum cultures or rapid antigen detection kits but also clinical features or gram staining of sputum.</p>","PeriodicalId":49031,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"11 ","pages":"25"},"PeriodicalIF":2.3,"publicationDate":"2016-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s40248-016-0060-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34498787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Prospective study of the efficacy of antibiotics versus antitussive drugs for the management of URTI-related acute cough in children. 抗生素与止咳药治疗儿童尿路感染相关急性咳嗽疗效的前瞻性研究。
IF 2.3 Pub Date : 2016-06-13 eCollection Date: 2016-01-01 DOI: 10.1186/s40248-016-0059-y
Alessandro Zanasi, Luigi Lanata, Federico Saibene, Giovanni Fontana, Peter V Dicpinigaitis, Valentina Venier, Francesco De Blasio

Background: Acute cough is one of the most frequent symptoms prompting a visit to a health care provider, usually following a viral upper respiratory tract infection (URTI). The disproportionate use of antibiotics in children with URTIs, recently highlighted in the medical literature, could lead to associated side effects, without any beneficial effect. Although an early, albeit inappropriate, antibiotic prescription increases parental satisfaction, URTIs are predominantly viral infections and are generally self-limiting. Therefore the aim of this study was to analyze the effectiveness of antibiotics compared to symptomatic drugs (central and peripheral antitussives) on URTI-related cough in a pediatric population.

Methods: This is a prospective observational study of 330 children who required pediatric consultation for acute cough. Severity, frequency and type of cough were assessed at baseline and after 6 days of treatment (antitussives n = 123, antibiotics n = 89 or combination of them n = 38) or no treatment (n = 80). The outcome of cough management after 6 days was analyzed in terms of resolution, improvement, no change or worsening of symptoms. Study assessments were performed using a standardized questionnaire administered to parents.

Results: Between children treated with antitussives or antibiotics, there was a statistically significant difference in the resolution of cough. Moreover, if considering peripheral antitussives, the resolution of cough was significantly higher with antitussives than with antibiotics (p < 0.01). There was no difference in cough resolution between children treated with antitussives and those receiving a combination of antibiotics and antitussives, either central and peripheral antitussives.

Conclusion: Antibiotics are generally not useful nor appropriate in treating acute cough due to the common cold. Furthermore, inappropriate antibiotic use introduces the possibility of adverse side effects as well as promotion of antibiotic resistance. The findings of the present study suggest that antitussives, especially peripherally acting agents, represent an effective treatment option for acute pediatric cough caused by URTIs.

背景:急性咳嗽通常是病毒性上呼吸道感染(URTI)后最常见的症状之一,促使人们去看卫生保健提供者。最近在医学文献中强调,在患有尿路感染的儿童中过度使用抗生素可能导致相关的副作用,而没有任何有益的效果。尽管早期不适当的抗生素处方可以提高父母的满意度,但尿路感染主要是病毒感染,通常是自限性的。因此,本研究的目的是分析抗生素与对症药物(中枢和外周止咳药)相比,在儿科人群中治疗尿路感染相关咳嗽的有效性。方法:这是一项前瞻性观察研究,330名儿童因急性咳嗽就诊。在基线和治疗6天后(抗咳药123例,抗生素89例或联合使用38例)或未治疗(80例)评估咳嗽的严重程度、频率和类型。分析6天后咳嗽处理的结果,包括症状缓解、改善、无变化或恶化。研究评估是通过对家长进行标准化问卷调查进行的。结果:两组患儿咳嗽缓解程度差异有统计学意义。此外,如果考虑外周性止咳药,咳嗽的缓解率明显高于抗生素(p结论:抗生素在治疗普通感冒引起的急性咳嗽中一般无效,也不合适。此外,不适当的抗生素使用会带来不良副作用的可能性,并促进抗生素耐药性。本研究的结果表明,抗咳药,特别是外周作用的药物,是治疗小儿泌尿道感染引起的急性咳嗽的有效选择。
{"title":"Prospective study of the efficacy of antibiotics versus antitussive drugs for the management of URTI-related acute cough in children.","authors":"Alessandro Zanasi,&nbsp;Luigi Lanata,&nbsp;Federico Saibene,&nbsp;Giovanni Fontana,&nbsp;Peter V Dicpinigaitis,&nbsp;Valentina Venier,&nbsp;Francesco De Blasio","doi":"10.1186/s40248-016-0059-y","DOIUrl":"https://doi.org/10.1186/s40248-016-0059-y","url":null,"abstract":"<p><strong>Background: </strong>Acute cough is one of the most frequent symptoms prompting a visit to a health care provider, usually following a viral upper respiratory tract infection (URTI). The disproportionate use of antibiotics in children with URTIs, recently highlighted in the medical literature, could lead to associated side effects, without any beneficial effect. Although an early, albeit inappropriate, antibiotic prescription increases parental satisfaction, URTIs are predominantly viral infections and are generally self-limiting. Therefore the aim of this study was to analyze the effectiveness of antibiotics compared to symptomatic drugs (central and peripheral antitussives) on URTI-related cough in a pediatric population.</p><p><strong>Methods: </strong>This is a prospective observational study of 330 children who required pediatric consultation for acute cough. Severity, frequency and type of cough were assessed at baseline and after 6 days of treatment (antitussives n = 123, antibiotics n = 89 or combination of them n = 38) or no treatment (n = 80). The outcome of cough management after 6 days was analyzed in terms of resolution, improvement, no change or worsening of symptoms. Study assessments were performed using a standardized questionnaire administered to parents.</p><p><strong>Results: </strong>Between children treated with antitussives or antibiotics, there was a statistically significant difference in the resolution of cough. Moreover, if considering peripheral antitussives, the resolution of cough was significantly higher with antitussives than with antibiotics (p < 0.01). There was no difference in cough resolution between children treated with antitussives and those receiving a combination of antibiotics and antitussives, either central and peripheral antitussives.</p><p><strong>Conclusion: </strong>Antibiotics are generally not useful nor appropriate in treating acute cough due to the common cold. Furthermore, inappropriate antibiotic use introduces the possibility of adverse side effects as well as promotion of antibiotic resistance. The findings of the present study suggest that antitussives, especially peripherally acting agents, represent an effective treatment option for acute pediatric cough caused by URTIs.</p>","PeriodicalId":49031,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"11 ","pages":"29"},"PeriodicalIF":2.3,"publicationDate":"2016-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s40248-016-0059-y","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34575015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
Need of education for dry powder inhaler storage and retention - a patient-reported survey. 需要对干粉吸入器的储存和保留进行教育-一项患者报告的调查。
IF 2.3 Pub Date : 2016-06-08 eCollection Date: 2016-01-01 DOI: 10.1186/s40248-016-0057-0
Birger Norderud Lærum, Gunilla Telg, Georgios Stratelis

Background: Dry powder inhalers (DPIs) are the most commonly used devices in asthma treatment in the Nordic countries. As new DPIs become available, patients are likely to be exposed to more than one type of device, with variable optimal handling. The aim was to examine real life storage and retention of multidose DPIs in patients with asthma.

Methods: This patient-reported survey on real life storage and retention of DPIs included asthma patients using multidose DPIs. Basic patient characteristics, information on inhaler use and storage, check of expiry date, and concurrent inhaler use was examined using an on line questionnaire.

Results: A total of 738 patients were included with a median age of 41 years, out of which 83 % were women. Sixty-three per cent reported storage conditions pre-defined as risk locations for their maintenance inhaler and 38 % of the responding patients had more than one maintenance inhaler in use at the same time. Two thirds of the study population checked inhaler expiry date less than monthly or not at all. Use after expiry date was frequently reported. Two thirds of the patients had not received information on DPI storage, either from their doctor and/or nurse or at the pharmacy.

Conclusions: This patient reported survey indicates that two thirds of the patients store their inhaler devices in suboptimal conditions, and only a minority had received instruction regarding inhaler handling. Non awareness of inhalers' expiry dates and use of more than one maintenance inhaler simultaneously was common. As inhaler mishandling may impact device functionality, improved communication and patient education is needed.

背景:干粉吸入器(dpi)是北欧国家哮喘治疗中最常用的设备。随着新的dpi的出现,患者可能会接触到多种类型的设备,其最佳处理方式也不尽相同。目的是检查哮喘患者多剂量dpi的实际储存和保留。方法:采用多剂量dpi的哮喘患者作为研究对象,对dpi在现实生活中的储存和保留情况进行调查。使用在线问卷调查了患者的基本特征、吸入器使用和储存信息、有效期检查和同时使用吸入器的情况。结果:共纳入738例患者,中位年龄41岁,其中83%为女性。63%的患者报告了预先定义为其维持吸入器风险位置的储存条件,38%的应答患者同时使用一个以上的维持吸入器。三分之二的研究人群检查吸入器的有效期少于一个月或根本没有。经常报告过期后使用。三分之二的患者没有从他们的医生和/或护士或药房获得关于DPI存储的信息。结论:该患者报告的调查表明,三分之二的患者将吸入器装置储存在不理想的条件下,只有少数人接受了有关吸入器处理的指导。不知道吸入器的有效期和同时使用一个以上的维持吸入器是很常见的。由于吸入器处理不当可能会影响设备的功能,因此需要改进沟通和患者教育。
{"title":"Need of education for dry powder inhaler storage and retention - a patient-reported survey.","authors":"Birger Norderud Lærum,&nbsp;Gunilla Telg,&nbsp;Georgios Stratelis","doi":"10.1186/s40248-016-0057-0","DOIUrl":"https://doi.org/10.1186/s40248-016-0057-0","url":null,"abstract":"<p><strong>Background: </strong>Dry powder inhalers (DPIs) are the most commonly used devices in asthma treatment in the Nordic countries. As new DPIs become available, patients are likely to be exposed to more than one type of device, with variable optimal handling. The aim was to examine real life storage and retention of multidose DPIs in patients with asthma.</p><p><strong>Methods: </strong>This patient-reported survey on real life storage and retention of DPIs included asthma patients using multidose DPIs. Basic patient characteristics, information on inhaler use and storage, check of expiry date, and concurrent inhaler use was examined using an on line questionnaire.</p><p><strong>Results: </strong>A total of 738 patients were included with a median age of 41 years, out of which 83 % were women. Sixty-three per cent reported storage conditions pre-defined as risk locations for their maintenance inhaler and 38 % of the responding patients had more than one maintenance inhaler in use at the same time. Two thirds of the study population checked inhaler expiry date less than monthly or not at all. Use after expiry date was frequently reported. Two thirds of the patients had not received information on DPI storage, either from their doctor and/or nurse or at the pharmacy.</p><p><strong>Conclusions: </strong>This patient reported survey indicates that two thirds of the patients store their inhaler devices in suboptimal conditions, and only a minority had received instruction regarding inhaler handling. Non awareness of inhalers' expiry dates and use of more than one maintenance inhaler simultaneously was common. As inhaler mishandling may impact device functionality, improved communication and patient education is needed.</p>","PeriodicalId":49031,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"11 ","pages":"21"},"PeriodicalIF":2.3,"publicationDate":"2016-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s40248-016-0057-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34560020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 18
Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/ Formoterol 100/6 μg b.i.d.: a 12-week cost analysis in mild-to-moderate asthma. 糠酸氟替卡松/维拉托醇92/22μg每日一次与二丙酸倍氯米松/福莫特罗100/6μg b.i.d.:轻度至中度哮喘的12周成本分析。
IF 2.3 Pub Date : 2016-06-06 eCollection Date: 2016-01-01 DOI: 10.1186/s40248-016-0055-2
Roberto W Dal Negro, Chiara Distante, Luca Bonadiman, Paola Turco, Sergio Iannazzo

Background: Asthma is a disease with high cost for the National Health Service. Two of the most recent LABA/ICS combinations for persistent bronchial asthma are Beclomethasone dipropionate/Formoterol (B/F) delivered via the Nexthaler device and Fluticasone furoate/Vilanterol (F/V) delivered via the Ellipta device. No comparison has been carried out yet in terms of cost analysis in asthma, to our knowledge. Aim of the present monocentric, observational, retrospective study was to calculate and compare the costs of mild-to-moderate asthma patients assuming B/F 100/6 μg b.i.d. to those of patients assuming F/V 92/22 μg once-a-day over a 12-week treatment period from the Italian National Health Service perspective.

Methods: Data were obtained automatically and anonymously from the institutional database of the Lung Unit of the Specialist Medical Centre (CEMS), Verona, Italy, UNI EN ISO 9001-2008 validated. FEV1 values, number of relapses, healthcare resources as hospitalizations due to asthma relapses, days of hospitalization, general practitioner (GP), specialist visits, and days of inactivity, were recorded over the study period together with the use of extra medications (systemic steroids and antibiotics). In order to compare the outcomes achieved in both groups, the propensity score matching method was used in STATA, and statistical significance was accepted for p < 0.05.

Results: Clinical data of 77 patients treated with B/F b.i.d (Group A) and of 40 patients treated with F/V 92/22 μg once-a-day (Group B) were selected. The PS-matching process, designed as matching on the baseline covariates, gender, age, FEV1 and comorbidities, returned a cohort of 40 group A patients of the entire cohort matched with 40 patients of group B, fully comparable for demographics and clinical characteristics. In the PS-matched cohort, the mean (±SE) number of relapses per patient during the follow-up was 0.53 (±0.12) in group A and 0.28 (±0.07) in group B. In group A, n = 25 (62.50 %), n = 9 (22.50 %), and n = 6 (15 %) patients had 0, 1, 2 relapses, respectively. In group B, n = 29 (72.50 %), and n = 11 (27.50 %) had 0 and 1 relapse, respectively. Over the study period, the average number of hospitalizations per patient was 0.15 (±0.06), with 0.28 (±0.12) days of hospitalization in group A, and 0.08 (±0.04) with 0.08 (±0.04) days of hospitalization in group B, respectively. The difference between the two groups in terms of FEV1(L) improvement vs baseline was 0.11 in favour of group B (p = 0.007). When results were compared, the improvement in lung function obtained in group B proved significantly higher both in terms of absolute FEV1 and of FEV1 % predicted. The mean (±SE) cost of hospitalizations per patient was € 345.30 (±133.23) in group A and € 172.65 (±98.18) in group B, respectively, with a mean not significant difference of - € 172.65 in favour of group B (p = 0.9). In particular, the mean (±SE

背景:哮喘是国民健康服务的高费用疾病。最近用于治疗持续性支气管哮喘的两种LABA/ICS组合是通过Nexthaler装置给药的二丙酸倍氯米松/福莫特罗(B/F)和通过Ellipta装置给药的糠酸氟替卡松/维兰特罗(F/V)。据我们所知,在哮喘的成本分析方面还没有进行过比较。本单中心、观察性、回顾性研究的目的是从意大利国家卫生服务的角度,计算和比较在12周的治疗期间,每日服用一次B/F 100/6 μg的轻中度哮喘患者和每天服用一次F/V 92/22 μg的患者的成本。方法:数据从意大利维罗纳专科医疗中心(CEMS)肺科机构数据库自动匿名获取,UNI EN ISO 9001-2008验证。在研究期间记录FEV1值、哮喘复发次数、因哮喘复发而住院的医疗资源、住院天数、全科医生(GP)、专科就诊和不活动天数,以及额外药物(全身性类固醇和抗生素)的使用。为比较两组疗效,STATA采用倾向评分匹配法,p值具有统计学意义。结果:选取B/F双抗组77例患者(A组)和F/V 92/22 μg / d组40例患者(B组)的临床资料。ps匹配过程设计为对基线协变量、性别、年龄、FEV1和合并症进行匹配,将整个队列中的40名a组患者与40名B组患者进行匹配,在人口统计学和临床特征上完全可比。在ps匹配的队列中,随访期间每位患者复发的平均(±SE)数A组为0.53(±0.12)次,b组为0.28(±0.07)次。A组有25例(62.50%)、9例(22.50%)、6例(15%)患者分别有0、1、2次复发。B组29例(72.50%)复发,11例(27.50%)复发。研究期间,A组患者平均住院时间为0.15(±0.06)天,住院时间为0.28(±0.12)天;B组患者平均住院时间为0.08(±0.04)天,住院时间为0.08(±0.04)天。两组在FEV1(L)改善方面与基线相比的差异为0.11,有利于B组(p = 0.007)。当结果比较时,B组肺功能的改善在绝对FEV1和预测FEV1 %方面都被证明明显更高。A组每位患者的平均住院费用(±SE)分别为345.30欧元(±133.23)和172.65欧元(±98.18),B组平均无显著差异- 172.65欧元(p = 0.9)。特别是,A组每位患者就诊的平均(±SE)费用为26.82欧元(±3.73欧元),B组为11.36欧元(±2.30欧元)(p = 0.002), A组为35.24欧元(±6.93欧元),B组为18.73欧元(±3.38欧元)(p = 0.05)。结论:即使在有限的一段时间内检查ICS/LABA组合,它们在对肺功能的影响和对轻中度哮喘的经济影响方面似乎具有不同的特征。与二丙酸倍氯米松/福莫特罗100/6 μg / d相比,每日一次联合吸入糠酸氟替卡松/维兰特罗92/22 μg显示出增强临床结果和降低成本的潜力。
{"title":"Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/ Formoterol 100/6 μg b.i.d.: a 12-week cost analysis in mild-to-moderate asthma.","authors":"Roberto W Dal Negro,&nbsp;Chiara Distante,&nbsp;Luca Bonadiman,&nbsp;Paola Turco,&nbsp;Sergio Iannazzo","doi":"10.1186/s40248-016-0055-2","DOIUrl":"https://doi.org/10.1186/s40248-016-0055-2","url":null,"abstract":"<p><strong>Background: </strong>Asthma is a disease with high cost for the National Health Service. Two of the most recent LABA/ICS combinations for persistent bronchial asthma are Beclomethasone dipropionate/Formoterol (B/F) delivered via the Nexthaler device and Fluticasone furoate/Vilanterol (F/V) delivered via the Ellipta device. No comparison has been carried out yet in terms of cost analysis in asthma, to our knowledge. Aim of the present monocentric, observational, retrospective study was to calculate and compare the costs of mild-to-moderate asthma patients assuming B/F 100/6 μg b.i.d. to those of patients assuming F/V 92/22 μg once-a-day over a 12-week treatment period from the Italian National Health Service perspective.</p><p><strong>Methods: </strong>Data were obtained automatically and anonymously from the institutional database of the Lung Unit of the Specialist Medical Centre (CEMS), Verona, Italy, UNI EN ISO 9001-2008 validated. FEV1 values, number of relapses, healthcare resources as hospitalizations due to asthma relapses, days of hospitalization, general practitioner (GP), specialist visits, and days of inactivity, were recorded over the study period together with the use of extra medications (systemic steroids and antibiotics). In order to compare the outcomes achieved in both groups, the propensity score matching method was used in STATA, and statistical significance was accepted for p < 0.05.</p><p><strong>Results: </strong>Clinical data of 77 patients treated with B/F b.i.d (Group A) and of 40 patients treated with F/V 92/22 μg once-a-day (Group B) were selected. The PS-matching process, designed as matching on the baseline covariates, gender, age, FEV1 and comorbidities, returned a cohort of 40 group A patients of the entire cohort matched with 40 patients of group B, fully comparable for demographics and clinical characteristics. In the PS-matched cohort, the mean (±SE) number of relapses per patient during the follow-up was 0.53 (±0.12) in group A and 0.28 (±0.07) in group B. In group A, n = 25 (62.50 %), n = 9 (22.50 %), and n = 6 (15 %) patients had 0, 1, 2 relapses, respectively. In group B, n = 29 (72.50 %), and n = 11 (27.50 %) had 0 and 1 relapse, respectively. Over the study period, the average number of hospitalizations per patient was 0.15 (±0.06), with 0.28 (±0.12) days of hospitalization in group A, and 0.08 (±0.04) with 0.08 (±0.04) days of hospitalization in group B, respectively. The difference between the two groups in terms of FEV1(L) improvement vs baseline was 0.11 in favour of group B (p = 0.007). When results were compared, the improvement in lung function obtained in group B proved significantly higher both in terms of absolute FEV1 and of FEV1 % predicted. The mean (±SE) cost of hospitalizations per patient was € 345.30 (±133.23) in group A and € 172.65 (±98.18) in group B, respectively, with a mean not significant difference of - € 172.65 in favour of group B (p = 0.9). In particular, the mean (±SE","PeriodicalId":49031,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"11 ","pages":"20"},"PeriodicalIF":2.3,"publicationDate":"2016-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s40248-016-0055-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34558430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
期刊
Multidisciplinary Respiratory Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1